Sign in

    Michael F. Mahoney

    President and Chief Executive Officer at Boston Scientific Corp
    Board
    Since November 2012
    Age
    59 years
    Education
    Holds a B.B.A. in Finance from the University of Iowa and an M.B.A. from Wake Forest University.
    Tenure
    Joined BSX in October 2011 as President, was promoted to President and Chief Executive Officer in November 2012, and appointed Chairman of the Board in May 2016.

    Also at Boston Scientific Corp

    DJB
    Daniel J. Brennan
    Executive Vice President and Chief Financial Officer
    WC
    Wendy Carruthers
    Executive Vice President, Human Resources
    ACB
    Arthur C. Butcher
    Executive Vice President and Group President, MedSurg and Asia Pacific

    About

    At 59 years old , he has built an impressive foundation in business and leadership, underpinned by his studies in finance and administration. Holds a B.B.A. in Finance from the University of Iowa and an M.B.A. from Wake Forest University, which set the stage for a career marked by progressive responsibilities.

    Beginning his career at General Electric Medical Systems, he quickly ascended through the ranks, later serving as President and CEO of Global Healthcare Exchange and holding key leadership roles at Johnson & Johnson. He joined BSX as President in October 2011 and was promoted to President and Chief Executive Officer in November 2012, before being appointed Chairman of the Board in May 2016.

    Beyond his roles at BSX, he has also contributed significantly to the broader healthcare sector through board memberships with prominent companies and participation in non-profit activities. His leadership style, characterized by a focus on operational excellence and strategic vision, has been instrumental in steering the company through dynamic market challenges.

    $BSX Performance Under Michael F. Mahoney

    Past Roles

    OrganizationRoleDate RangeDetails
    Boston Scientific Corporation President, CEO, and Director Nov 2012 - May 2016 Transitioned to also assume Chairman role later
    Boston Scientific Corporation President Oct 2011 - Nov 2012 Joined BSX as President
    Johnson & Johnson Worldwide Chairman, Medical Devices and Diagnostics Division Jan 2011 - Sep 2011 Oversaw 50,000 employees and seven franchises
    Johnson & Johnson Worldwide Group Chairman, DePuy Franchise Apr 2007 - Jan 2011 Managed the orthopedics and neurosciences business
    Global Healthcare Exchange President and CEO Jan 2001 - Mar 2007 Led provider of supply chain solutions connecting hospitals, manufacturers, distributors, and GPOs
    General Electric Medical Systems General Manager, Healthcare IT Business N/A Held various roles over 12 years, culminating in this position

    External Roles

    OrganizationRoleDate RangeDetails
    CVS Health Corporation Board Member N/A Current board member
    Boys & Girls Club of Boston Involved N/A Active involvement
    Boston College CEO Club Chair of the Board of Governors N/A N/A
    American Heart Association CEO Roundtable Member N/A N/A

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$1,400,000 Annual 2024N/A
    401(k) Plan Match$20,700 Annual 2024N/A
    Term Life Insurance$4,902 Annual 2024N/A
    Aircraft Usage$150,000 Annual 2024N/A
    Financial Planning$13,650 Annual 2024N/A
    Other Compensation (Miscellaneous)$4,142 Annual 2024N/A
    Change in Pension Value and Nonqualified Deferred Compensation Earnings$291,666 Annual 2024N/A

    Performance Compensation

    Data from  FY 2024

    Performance-Based RSUs

    MetricValueUnit/Detail
    rTSR Threshold16,444 RSUs
    rTSR Target54,816 RSUs
    rTSR Maximum109,632 RSUs
    ONSG Threshold27,408 RSUs
    ONSG Target54,816 RSUs
    ONSG Maximum109,632 RSUs
    Grant DateFebruary 12, 2024 Date
    Grant Date Stock Price$64.99 per share
    Grant Date Fair Value (each)$3,562,492 USD
    Vesting Schedule3-year period ending December 31, 2026 N/A
    Actual Performance200% of target N/A

    Option Awards (Equity Incentive Plan)

    MetricValueUnit/Detail
    Grant DateFebruary 12, 2024 Date
    Exercise Price$64.99 per share
    Number of Options144,516 Options
    Grant Date Fair Value$3,562,493 USD
    Vesting Schedule4 equal annual installments N/A

    Non-Equity Incentive Plan Compensation (Annual Bonus Plan)

    MetricValueUnit/Detail
    Target Annual Award$2,170,000 USD
    Applicable Distribution Percentage150% Percentage
    Individual Performance Modifier115% Percentage
    Actual ABP Award$3,743,000 USD
    Maximum Payout225% of target Percentage of Target

    Grants of Plan-Based Awards - Equity Incentive Award 1

    MetricValueUnit/Detail
    Performance MetricsrTSR & ONSG RSUs metrics
    rTSR Threshold16,444 Shares
    rTSR Target54,816 Shares
    rTSR Maximum109,632 Shares
    Grant DateFebruary 12, 2024 Date
    Grant Date Fair Value$7,124,984 USD (target ONSG performance-based RSUs)
    Grant Date Stock Price$64.99 per share
    Vesting Schedule4 equal annual installments N/A

    Grants of Plan-Based Awards - Equity Incentive Award 2

    MetricValueUnit/Detail
    Performance MetricrTSR RSUs metric
    Threshold27,408 Shares
    Target54,816 Shares
    Maximum109,632 Shares
    Grant DateFebruary 12, 2024 Date
    Date ApprovedFebruary 6, 2024 Date
    Grant Date Fair Value$3,562,492 USD
    Grant Date Stock Price$64.99 per share
    Vesting Schedule4 equal annual installments N/A
    Monte Carlo AssumptionsRisk-Free Rate: 4.23%, Measurement Period: 2.88 years N/A